Potential of Actinobacillus succinogenes for Industrial Succinate Production
Author Information
Author(s): McKinlay James B, Laivenieks Maris, Schindler Bryan D, McKinlay Anastasia A, Siddaramappa Shivakumara, Challacombe Jean F, Lowry Stephen R, Clum Alicia, Lapidus Alla L, Burkhart Kirk B, Harkins Victoria, Vieille Claire
Primary Institution: Michigan State University
Hypothesis
Can Actinobacillus succinogenes be genetically engineered to enhance succinate production for industrial applications?
Conclusion
Actinobacillus succinogenes and Mannheimia succiniciproducens lack many virulence genes, indicating their potential as safe organisms for industrial succinate production.
Supporting Evidence
- A. succinogenes can convert sugars and CO2 into succinic acid.
- The genome sequence reveals metabolic pathways that can be engineered for improved succinate production.
- A. succinogenes lacks pathogenic traits found in other related bacteria.
- Natural competence in A. succinogenes suggests potential for genetic modifications.
Takeaway
This study shows that a bacterium called Actinobacillus succinogenes can make a useful chemical called succinate, and it doesn't make people sick.
Methodology
The genome of Actinobacillus succinogenes was sequenced and analyzed for metabolic capabilities and genetic engineering potential.
Limitations
The study primarily focuses on genomic analysis and does not include experimental validation of metabolic engineering outcomes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website